Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients

doi:10.3748/wjg.v21.i43.12410

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 43

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8085)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

552

WORD

341

HTML

4228

Figures (1-3)

156

Tables (1-3)

138

Sum=5415

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1201

Download

1469

Sum=2670

Nov 21, 2015 (publication date) through Apr 17, 2024

Times Cited of This Article

Times Cited (50)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Nov 21, 2015; 21(43): 12410-12420
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12410

Full Size Figure Download Figure

Figure 2 Overall survival of enrolled patients according to the systemic inflammation markers. Overall survival of total enrolled patients (A), overall survival according to modified Glasgow prognostic score (B), neutrophil lymphocyte ratio (C), platelet lymphocyte ratio (D), prognostic nutritional index (E), and lymphocyte monocyte ratio (F).

Citation: Song A, Eo W, Lee S. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients. World J Gastroenterol 2015; 21(43): 12410-12420
URL: https://www.wjgnet.com/1007-9327/full/v21/i43/12410.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i43.12410